Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2021

01-10-2021 | Eosinophilic Esophagitis | Original Article

Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis

Authors: Nicole Chang, Soha Raja, Renee Betancourt, Cara Randall, Staci Keene, Amy Lilly, Mark Fowler, John T. Woosley, Nicholas J. Shaheen, Evan S. Dellon

Published in: Digestive Diseases and Sciences | Issue 10/2021

Login to get access

Abstract

Background

The relationship between histologic disease activity in eosinophilic esophagitis (EoE) and generic measures of quality of life (QoL) is unclear.

Aims

To determine differences in QoL in adults with EoE based on histologic activity and assess changes in QoL over time.

Methods

We performed an analysis of prospectively collected data from patients in the University of North Carolina EoE Registry. Patients were categorized with histologically active (≥ 15 eosinophils per high-power field [eos/hpf]) or inactive (< 15 eos/hpf) disease. Dysphagia severity was measured with a Likert scale. QoL was measured with 36-Item Short Form (SF-36), compared between active and inactive groups, and assessed longitudinally.

Results

Of 147 EoE cases, those with inactive disease (n = 56) reported less dysphagia severity (3.2 vs. 1.9; p = 0.003) and had lower endoscopic severity (3.8 vs. 1.0; p < 0.001) than those with active disease (n = 91). While SF-36 scores did not differ between active and inactive status, lower mental component scores (MCS) were seen in patients treated with empiric dietary elimination (44.9 vs. 50.8; p = 0.005). Dysphagia severity was negatively correlated with both physical component score (PCS) (r = −0.33; p < 0.001) and MCS (r = −0.18; p = 0.03). Despite more cases achieving histologic response over time, SF-36 scores did not improve on either raw or adjusted analyses.

Conclusion

QoL measured by SF-36 in EoE was similar regardless of histologic disease activity and was in the range of population averages. General QoL metrics like the SF-36 do not appear to have substantial utility in EoE.
Literature
1.
go back to reference Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology. 2018;155:1022–1033.CrossRef Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology. 2018;155:1022–1033.CrossRef
2.
go back to reference Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319–332.CrossRef Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319–332.CrossRef
3.
go back to reference O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154:333–345.CrossRef O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154:333–345.CrossRef
4.
go back to reference Jensen ET, Kappelman MD, Martin CF, Dellon ES. Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States. Am J Gastroenterol. 2015;110:626.CrossRef Jensen ET, Kappelman MD, Martin CF, Dellon ES. Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States. Am J Gastroenterol. 2015;110:626.CrossRef
5.
go back to reference Hiremath G, Kodroff E, Strobel MJ, et al. Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care. Clin Res Hepatol Gastroenterol. 2018;42:483–493.CrossRef Hiremath G, Kodroff E, Strobel MJ, et al. Individuals affected by eosinophilic gastrointestinal disorders have complex unmet needs and frequently experience unique barriers to care. Clin Res Hepatol Gastroenterol. 2018;42:483–493.CrossRef
6.
go back to reference Mukkada V, Falk GW, Eichinger CS, King D, Todorova L, Shaheen NJ. Health-related quality of life and costs associated with eosinophilic esophagitis: A systematic review. Clin Gastroenterol Hepatol. 2018;16:495–503.CrossRef Mukkada V, Falk GW, Eichinger CS, King D, Todorova L, Shaheen NJ. Health-related quality of life and costs associated with eosinophilic esophagitis: A systematic review. Clin Gastroenterol Hepatol. 2018;16:495–503.CrossRef
7.
go back to reference Van Rhijn BD, Smout AJPM, Bredenoord AJ. Disease duration determines health-related quality of life in adult eosinophilic esophagitis patients. Neurogastroenterol Motil. 2014;26:772–778.CrossRef Van Rhijn BD, Smout AJPM, Bredenoord AJ. Disease duration determines health-related quality of life in adult eosinophilic esophagitis patients. Neurogastroenterol Motil. 2014;26:772–778.CrossRef
8.
go back to reference Hewett R, Alexakis C, Farmer AD, et al. Effects of eosinophilic oesophagitis on quality of life in an adult UK population: A case control study. Dis Esophagus. 2017;30:1–7.PubMed Hewett R, Alexakis C, Farmer AD, et al. Effects of eosinophilic oesophagitis on quality of life in an adult UK population: A case control study. Dis Esophagus. 2017;30:1–7.PubMed
9.
go back to reference Safroneeva E, Coslovsky M, Kuehni CE, et al. Eosinophilic oesophagitis: Relationship of quality of life with clinical, endoscopic and histological activity. Aliment Pharmacol Ther. 2015;42:1000–1010.CrossRef Safroneeva E, Coslovsky M, Kuehni CE, et al. Eosinophilic oesophagitis: Relationship of quality of life with clinical, endoscopic and histological activity. Aliment Pharmacol Ther. 2015;42:1000–1010.CrossRef
10.
go back to reference Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á. Determinant factors of quality of life in adult patients with eosinophilic esophagitis. United Eur Gastroenterol J. 2018;6:38–45.CrossRef Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á. Determinant factors of quality of life in adult patients with eosinophilic esophagitis. United Eur Gastroenterol J. 2018;6:38–45.CrossRef
11.
go back to reference Larsson H, Bergman K, Finizia C, Johansson L, Bove M, Bergquist H. Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up. Eur Arch Oto-Rhino-Laryngology. 2015;272:3833–3839.CrossRef Larsson H, Bergman K, Finizia C, Johansson L, Bove M, Bergquist H. Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up. Eur Arch Oto-Rhino-Laryngology. 2015;272:3833–3839.CrossRef
12.
go back to reference Bergquist H, Larsson H, Johansson L, Bove M. Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: A pilot study. Otolaryngol—Head Neck Surg. 2011;145:551–556.CrossRef Bergquist H, Larsson H, Johansson L, Bove M. Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: A pilot study. Otolaryngol—Head Neck Surg. 2011;145:551–556.CrossRef
13.
go back to reference Klinnert MD, Silveira L, Harris R, et al. Health-related quality of life over time in children with eosinophilic esophagitis and their families. J Pediatr Gastroenterol Nutr. 2014;59:308.CrossRef Klinnert MD, Silveira L, Harris R, et al. Health-related quality of life over time in children with eosinophilic esophagitis and their families. J Pediatr Gastroenterol Nutr. 2014;59:308.CrossRef
14.
go back to reference Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.CrossRef Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.CrossRef
15.
go back to reference Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.CrossRef Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.CrossRef
16.
go back to reference Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.CrossRef Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692.CrossRef
17.
go back to reference Reed CC, Wolf WA, Cotton CC, Dellon ES. A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;45:1443–1448.CrossRef Reed CC, Wolf WA, Cotton CC, Dellon ES. A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;45:1443–1448.CrossRef
18.
go back to reference Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: Validation of a novel classification and grading system. Gut. 2013;62:489–495.CrossRef Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: Validation of a novel classification and grading system. Gut. 2013;62:489–495.CrossRef
19.
go back to reference Wolf WA, Cotton CC, Green DJ, et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res. 2015;4:1780.CrossRef Wolf WA, Cotton CC, Green DJ, et al. Evaluation of histologic cutpoints for treatment response in eosinophilic esophagitis. J Gastroenterol Hepatol Res. 2015;4:1780.CrossRef
20.
go back to reference Reed CC, Wolf WA, Cotton CC, et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: Analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol. 2018;16:226–233.CrossRef Reed CC, Wolf WA, Cotton CC, et al. Optimal histologic cutpoints for treatment response in patients with eosinophilic esophagitis: Analysis of data from a prospective cohort study. Clin Gastroenterol Hepatol. 2018;16:226–233.CrossRef
21.
go back to reference Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek AE. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264–AS279.CrossRef Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek AE. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264–AS279.CrossRef
22.
go back to reference Ware JEJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.CrossRef Ware JEJ, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.CrossRef
23.
go back to reference Franciosi JP, Hommel KA, Debrosse CW, et al. Quality of life in paediatric eosinophilic oesophagitis: What is important to patients? Child Care Health Dev. 2012;38:477–483.CrossRef Franciosi JP, Hommel KA, Debrosse CW, et al. Quality of life in paediatric eosinophilic oesophagitis: What is important to patients? Child Care Health Dev. 2012;38:477–483.CrossRef
24.
go back to reference Aceves SS, King E, Collins MH, et al. Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites. J Allergy Clin Immunol. 2018;142:130–138.CrossRef Aceves SS, King E, Collins MH, et al. Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites. J Allergy Clin Immunol. 2018;142:130–138.CrossRef
25.
go back to reference Hiremath G, Rogers E, Kennedy E, Hemler J, Acra S. A comparative analysis of eating behavior of school-aged children with eosinophilic esophagitis and their caregivers’ quality of life: perspectives of caregivers. Dysphagia. 2019;34:567–574.CrossRef Hiremath G, Rogers E, Kennedy E, Hemler J, Acra S. A comparative analysis of eating behavior of school-aged children with eosinophilic esophagitis and their caregivers’ quality of life: perspectives of caregivers. Dysphagia. 2019;34:567–574.CrossRef
26.
go back to reference Safroneeva E, Balsiger L, Hafner D, et al. Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes. Aliment Pharmacol Ther. 2018;48:1082–1090.CrossRef Safroneeva E, Balsiger L, Hafner D, et al. Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes. Aliment Pharmacol Ther. 2018;48:1082–1090.CrossRef
27.
go back to reference Stern E, Taft T, Zalewski A, Gonsalves N, Hirano I. Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis. Dis Esophagus. 2018;31:dox128. Stern E, Taft T, Zalewski A, Gonsalves N, Hirano I. Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis. Dis Esophagus. 2018;31:dox128.
28.
go back to reference Maglinte GA, Hays RD, Kaplan RM. US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol. Published online 2012. Maglinte GA, Hays RD, Kaplan RM. US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol. Published online 2012.
29.
go back to reference Doll HA, Petersen SEK, Stewart-Brown SL. Obesity and physical and emotional well-being: Associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. Published online 2000. Doll HA, Petersen SEK, Stewart-Brown SL. Obesity and physical and emotional well-being: Associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire. Obes Res. Published online 2000.
30.
go back to reference Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: A population survey. Med J Aust. Published online 2003. Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: A population survey. Med J Aust. Published online 2003.
32.
go back to reference Gonsalves N, Doerfler B, Schwartz S, et al. Prospective trial of four food elimination diet demonstrates comparable effectiveness in the treatment of adult and pediatric eosinophilic esophagitis. [Abstract]. Gastroenterology. 2013;144:S-154. Gonsalves N, Doerfler B, Schwartz S, et al. Prospective trial of four food elimination diet demonstrates comparable effectiveness in the treatment of adult and pediatric eosinophilic esophagitis. [Abstract]. Gastroenterology. 2013;144:S-154.
33.
go back to reference Schoepfer AM, Straumann A, Panczak R, et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147:1255–1266.CrossRef Schoepfer AM, Straumann A, Panczak R, et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147:1255–1266.CrossRef
Metadata
Title
Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis
Authors
Nicole Chang
Soha Raja
Renee Betancourt
Cara Randall
Staci Keene
Amy Lilly
Mark Fowler
John T. Woosley
Nicholas J. Shaheen
Evan S. Dellon
Publication date
01-10-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06719-z

Other articles of this Issue 10/2021

Digestive Diseases and Sciences 10/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.